130 related articles for article (PubMed ID: 29671585)
1. Ligand-Triggered Structural Changes in the M
Jiménez-Rosés M; Matsoukas MT; Caltabiano G; Cordomí A
J Chem Inf Model; 2018 May; 58(5):1074-1082. PubMed ID: 29671585
[TBL] [Abstract][Full Text] [Related]
2. Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor.
Miao Y; McCammon JA
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12162-12167. PubMed ID: 27791003
[TBL] [Abstract][Full Text] [Related]
3. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
5. Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor.
Xu J; Wang Q; Hübner H; Hu Y; Niu X; Wang H; Maeda S; Inoue A; Tao Y; Gmeiner P; Du Y; Jin C; Kobilka BK
Nat Commun; 2023 Jan; 14(1):376. PubMed ID: 36690613
[TBL] [Abstract][Full Text] [Related]
6. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.
Haga K; Kruse AC; Asada H; Yurugi-Kobayashi T; Shiroishi M; Zhang C; Weis WI; Okada T; Kobilka BK; Haga T; Kobayashi T
Nature; 2012 Jan; 482(7386):547-51. PubMed ID: 22278061
[TBL] [Abstract][Full Text] [Related]
7. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
8. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
[TBL] [Abstract][Full Text] [Related]
9. Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor.
Bock A; Bermudez M; Krebs F; Matera C; Chirinda B; Sydow D; Dallanoce C; Holzgrabe U; De Amici M; Lohse MJ; Wolber G; Mohr K
J Biol Chem; 2016 Jul; 291(31):16375-89. PubMed ID: 27298318
[TBL] [Abstract][Full Text] [Related]
10. Ligand-Specific Restriction of Extracellular Conformational Dynamics Constrains Signaling of the M
Bermudez M; Bock A; Krebs F; Holzgrabe U; Mohr K; Lohse MJ; Wolber G
ACS Chem Biol; 2017 Jul; 12(7):1743-1748. PubMed ID: 28585805
[TBL] [Abstract][Full Text] [Related]
11. Activation and allosteric modulation of a muscarinic acetylcholine receptor.
Kruse AC; Ring AM; Manglik A; Hu J; Hu K; Eitel K; Hübner H; Pardon E; Valant C; Sexton PM; Christopoulos A; Felder CC; Gmeiner P; Steyaert J; Weis WI; Garcia KC; Wess J; Kobilka BK
Nature; 2013 Dec; 504(7478):101-6. PubMed ID: 24256733
[TBL] [Abstract][Full Text] [Related]
12. Agonist-Specific Conformations of the M
Randáková A; Nelic D; Doležal V; El-Fakahany EE; Boulos J; Jakubík J
J Chem Inf Model; 2020 Apr; 60(4):2325-2338. PubMed ID: 32130001
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M
Pegoli A; She X; Wifling D; Hübner H; Bernhardt G; Gmeiner P; Keller M
J Med Chem; 2017 Apr; 60(8):3314-3334. PubMed ID: 28388054
[TBL] [Abstract][Full Text] [Related]
14. Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.
Schmitz J; van der Mey D; Bermudez M; Klöckner J; Schrage R; Kostenis E; Tränkle C; Wolber G; Mohr K; Holzgrabe U
J Med Chem; 2014 Aug; 57(15):6739-50. PubMed ID: 25051097
[TBL] [Abstract][Full Text] [Related]
15. Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy.
Xu J; Hu Y; Kaindl J; Risel P; Hübner H; Maeda S; Niu X; Li H; Gmeiner P; Jin C; Kobilka BK
Mol Cell; 2019 Jul; 75(1):53-65.e7. PubMed ID: 31103421
[TBL] [Abstract][Full Text] [Related]
16. Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.
Schrage R; Seemann WK; Klöckner J; Dallanoce C; Racké K; Kostenis E; De Amici M; Holzgrabe U; Mohr K
Br J Pharmacol; 2013 May; 169(2):357-70. PubMed ID: 23062057
[TBL] [Abstract][Full Text] [Related]
17. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
18. Regulation of signal transduction at M2 muscarinic receptor.
Krejcí A; Michal P; Jakubík J; Rícný J; Dolezal V
Physiol Res; 2004; 53 Suppl 1():S131-40. PubMed ID: 15119944
[TBL] [Abstract][Full Text] [Related]
19. Role of Conserved Tyrosine Lid Residues in the Activation of the M
Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C
Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation in monomers and oligomers of a G protein-coupled receptor.
Shivnaraine RV; Kelly B; Sankar KS; Redka DS; Han YR; Huang F; Elmslie G; Pinto D; Li Y; Rocheleau JV; Gradinaru CC; Ellis J; Wells JW
Elife; 2016 May; 5():. PubMed ID: 27151542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
